We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$150B
AUM Growth
+$12.9B
Cap. Flow
+$4.72B
Cap. Flow %
3.14%
Top 10 Hldgs %
14.8%
Holding
3,187
New
75
Increased
2,456
Reduced
443
Closed
56

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$175M
2
INTC icon
Intel
INTC
+$154M
3
AMZN icon
Amazon
AMZN
+$115M
4
IBM icon
IBM
IBM
+$97.2M
5
PLD icon
Prologis
PLD
+$92.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$156M
2
GGP
GGP Inc.
GGP
+$135M
3
TSM icon
TSMC
TSM
+$111M
4
DCT
DCT Industrial Trust Inc.
DCT
+$81.8M
5
XL
XL Group Ltd.
XL
+$59.6M

Sector Composition

Rank Sector Weight
1 Technology 16.59%
2 Financials 14.04%
3 Healthcare 13.2%
4 Industrials 10.93%
5 Consumer Discretionary 10.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRTK
2501
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.55M ﹤0.01%
159,527
+19,397
+14% +$196K
BOJA
2502
DELISTED
Bojangles', Inc. Common Stock
BOJA
$1.55M ﹤0.01%
98,525
+11,912
+14% +$169K
NGS icon
2503
Natural Gas Services Group
NGS
$474M
$1.54M ﹤0.01%
73,050
+268
+0.4% +$5.92K
SYRS
2504
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.54M ﹤0.01%
12,906
+1,697
+15% +$197K
LOCO icon
2505
El Pollo Loco
LOCO
$452M
$1.54M ﹤0.01%
122,456
+15,566
+15% +$190K
GLOG
2506
DELISTED
GASLOG LTD
GLOG
$1.54M ﹤0.01%
77,800
+4,000
+5% +$70.9K
INSY
2507
DELISTED
Insys Therapeutics, Inc.
INSY
$1.53M ﹤0.01%
151,756
+25,421
+20% +$203K
GHM icon
2508
Graham Corp
GHM
$1.28B
$1.53M ﹤0.01%
54,192
-1,378
-2% -$37.2K
VWTR
2509
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$1.52M ﹤0.01%
121,208
-1,219
-1% -$15K
FARM
2510
DELISTED
Farmer Brothers
FARM
$1.51M ﹤0.01%
57,196
+2,695
+5% +$77.2K
EGC
2511
DELISTED
Energy XXI Gulf Coast, Inc. Common Stock
EGC
$1.51M ﹤0.01%
180,226
+4,764
+3% +$41.6K
RUBY
2512
DELISTED
Rubius Therapeutics, Inc
RUBY
$1.5M ﹤0.01%
+62,653
New +$1.43M
AVLR
2513
DELISTED
Avalara, Inc.
AVLR
$1.5M ﹤0.01%
+42,831
New +$1.77M
VHC icon
2514
VirnetX Holding Corp
VHC
$61.4M
$1.48M ﹤0.01%
15,878
+1,583
+11% +$108K
APTX
2515
DELISTED
Aptinyx Inc. Common Stock
APTX
$1.47M ﹤0.01%
+50,844
New +$1.24M
DOVA
2516
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$1.46M ﹤0.01%
69,812
+44,108
+172% +$1.05M
CWK icon
2517
Cushman & Wakefield Ltd
CWK
$3.23B
$1.46M ﹤0.01%
+86,090
New +$1.54M
FC icon
2518
Franklin Covey
FC
$235M
$1.44M ﹤0.01%
60,827
+2,239
+4% +$55.8K
VSEC icon
2519
VSE Corp
VSEC
$6.79B
$1.44M ﹤0.01%
43,426
+115
+0.3% +$4.7K
AAIC
2520
DELISTED
Arlington Asset Investment Corp.
AAIC
$1.43M ﹤0.01%
153,435
+17,185
+13% +$175K
GPX
2521
DELISTED
GP Strategies Corp.
GPX
$1.43M ﹤0.01%
84,581
+7,158
+9% +$132K
ELF icon
2522
e.l.f. Beauty
ELF
$5.61B
$1.42M ﹤0.01%
111,841
+3,550
+3% +$48.8K
CNCE
2523
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$1.41M ﹤0.01%
95,187
AMRC icon
2524
Ameresco
AMRC
$1.37B
$1.41M ﹤0.01%
102,971
+5,251
+5% +$71.7K
VNTR
2525
DELISTED
Venator Materials PLC
VNTR
$1.4M ﹤0.01%
155,908
-5,476
-3% -$70.7K

Similar funds

Charles Schwab's Q3 2018 Portfolio in Review

As of Q3 2018, Charles Schwab held 3,187 positions worth $150B, up 9.4% from $137B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Charles Schwab deployed $4.72B of net new capital in Q3 2018, opening 75 new positions and adding to 2,456 existing holdings. Its largest new stake was KKR & Co: 895,988 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $156M trimmed.

  • Charles Schwab's largest Q3 2018 buy was KKR & Co: 895,988 shares worth $24.4M.
  • Charles Schwab added most to Microsoft in Q3 2018, an estimated $175M increase.
  • Charles Schwab's biggest Q3 2018 reduction was Apple, cutting an estimated $156M.
  • Charles Schwab fully exited GGP Inc. in Q3 2018, selling an estimated $135M.
  • Charles Schwab's ten largest holdings make up 15% of its $150B portfolio in Q3 2018.
  • Charles Schwab opened 75 new positions and closed 56 in Q3 2018.
  • Charles Schwab's portfolio value rose 9.4% quarter-over-quarter to $150B.

Based on Charles Schwab's 13F filing for Q3 2018, filed 13 Nov 2018.